A case study highlights hyperviscosity syndrome as a rare manifestation of immunoglobulin G kappa smoldering multiple myeloma, effectively treated with daratumumab. This finding contributes to the understanding of treatment options for this rare presentation.
hyperviscosity syndrome as a rare presentation of immunoglobulin g kappa smoldering multiple myeloma successfully treated with daratumumab
Original title: “Hyperviscosity Syndrome as a Rare Presentation of Immunoglobulin G Kappa Smoldering Multiple Myeloma Successfully Treated With Daratumumab.”